Accelerate® DS-813 Modified Cellulose Gum - FMC Corporation

Accelerate® DS-813 Modified Cellulose Gum (74811-65-7-3) Date: 11/04/2005
INHALATION LC50: Ac-Di-Sol Croscarmellose Sodium (similar product): > 0.13 mg/l (4 h)
(rat) Maximum attainable concentration - zero mortality
SENSITIZATION: Ac-Di-Sol Croscarmellose Sodium (similar product): (Skin) Non-sensitizing
(guinea pig)
ACUTE EFFECTS FROM OVEREXPOSURE: This product is expected to have low
oral, dermal and inhalation toxicity. It is expected to be irritating to the eyes and skin, and non-sensitizing
to the skin. No significant acute toxicological effects are expected.
CHRONIC EFFECTS FROM OVEREXPOSURE: Ac-Di-Sol® Croscarmellose
Sodium, a similar product, was negative (non-mutagenic) in the Ames test, and did not induce chromosome
aberrations in rats. A 90-day animal study showed no adverse effects when administered in the diet. No
adverse human effects known.
CARCINOGENICITY:
NTP: Not listed
IARC: Not listed
OSHA: Not listed
OTHER: Not Listed (ACGIH)
12. ECOLOGICAL INFORMATION
ENVIRONMENTAL DATA: No data available for the product. This product is not expected
to have significant environmental effects.
ECOTOXICOLOGICAL INFORMATION: No data available for the product. No
significant effects on aquatic organisms expected.
13. DISPOSAL CONSIDERATIONS
DISPOSAL METHOD: No special disposal methods are suggested. It is the user's responsibility
to comply with all applicable local, state, and federal laws, rules, regulations and standards.
14. TRANSPORT INFORMATION
U.S. DEPARTMENT OF TRANSPORTATION (DOT)
Page 5 of 8